OrbiMed’s TESARO, Inc. TSRO Stock Holding History

OrbiMed’s Portfolio TSRO Stock Details TSRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-67,281	Closed	-$2.63M	–	164
2018 Q3	$2.63M	Hold	67,281	–	–	0.03%	138
2018 Q2	$2.99M	Hold	67,281	–	–	0.04%	136
2018 Q1	$3.84M	Hold	67,281	–	–	0.05%	122
2017 Q4	$5.58M	Buy	+67,281	New	+$6.6M	0.07%	115
2017 Q3	–	Sell	-30,301	Closed	-$4.24M	–	153
2017 Q2	$4.24M	Sell	30,301 -16,899	-36%	-$2.45M	0.04%	121
2017 Q1	$7.26M	Hold	47,200	–	–	0.08%	107
2016 Q4	$6.35M	Buy	+47,200	New	+$5.95M	0.08%	104
2016 Q2	–	Sell	-1,912,000	Closed	-$84.2M	–	151
2016 Q1	$84.2M	Buy	1,912,000 +147,300	+8%	+$5.91M	0.89%	36
2015 Q4	$92.3M	Buy	1,764,700 +29,500	+2%	+$1.41M	0.84%	38
2015 Q3	$69.6M	Sell	1,735,200 -336,280	-16%	-$18.4M	0.7%	43
2015 Q2	$122M	Buy	2,071,480 +13,780	+0.7%	+$791K	1.02%	29
2015 Q1	$118M	Buy	2,057,700 +727,700	+55%	+$34.3M	1.01%	31
2014 Q4	$49.5M	Buy	+1,330,000	New	+$41M	0.47%	50
2014 Q2	–	Sell	-847,800	Closed	-$25M	–	149
2014 Q1	$25M	Buy	+847,800	New	+$26.7M	0.31%	55

Other funds holding TSRO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed's TSRO Position: Q4 2018 in Review

OrbiMed sold out of TESARO, Inc. (TSRO) in Q4 2018, closing a stake of 67,281 shares — an estimated $2.63M sold.

OrbiMed first reported a position in TSRO in Q1 2014 and held it in 14 quarters. The position peaked at $122M in Q2 2015. 221 funds tracked by Wall St. Rank hold TSRO as of Q4 2018.

OrbiMed reported no remaining TESARO, Inc. position as of Q4 2018 after selling out during the quarter.
OrbiMed sold 67,281 TESARO, Inc. shares in Q4 2018, an estimated $2.63M.
OrbiMed first reported a position in TESARO, Inc. in Q1 2014 and held it in 14 quarters.
OrbiMed's TESARO, Inc. position peaked at $122M in Q2 2015.
221 funds tracked by Wall St. Rank held TESARO, Inc. as of Q4 2018.

Based on OrbiMed's 13F filing for Q4 2018, filed 14 Feb 2019.